| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.89M | 2.43M | 2.02M | 4.70M | 4.15M | 3.28M |
| Gross Profit | 1.28M | 1.68M | 1.39M | -2.17M | -3.36M | -3.10M |
| EBITDA | -3.01M | -3.93M | -4.83M | -15.08M | -4.49M | -3.73M |
| Net Income | -5.17M | -6.93M | -7.55M | -17.87M | -6.65M | -5.76M |
Balance Sheet | ||||||
| Total Assets | 17.84M | 17.84M | 19.07M | 17.00M | 25.79M | 24.48M |
| Cash, Cash Equivalents and Short-Term Investments | 561.18K | 561.18K | 975.20K | 2.53M | 1.55M | 2.18M |
| Total Debt | 16.34M | 16.34M | 12.79M | 10.21M | 4.91M | 5.26M |
| Total Liabilities | 19.59M | 19.59M | 15.10M | 12.28M | 6.30M | 6.34M |
| Stockholders Equity | -1.75M | -1.75M | 3.98M | 4.73M | 19.49M | 18.14M |
Cash Flow | ||||||
| Free Cash Flow | -2.84M | -3.70M | -5.27M | -5.11M | -7.51M | -7.46M |
| Operating Cash Flow | -2.84M | -3.70M | -5.22M | -4.17M | -6.03M | -5.55M |
| Investing Cash Flow | -305.20K | -305.20K | -586.79K | -940.93K | -1.48M | -1.91M |
| Financing Cash Flow | 3.59M | 3.59M | 4.26M | 6.09M | 6.78M | 8.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | AU$43.04M | 9.54 | 20.77% | 4.55% | 66.80% | 625.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | AU$20.71M | 23.75 | 6.19% | ― | -6.52% | -20.79% | |
50 Neutral | AU$51.40M | -12.16 | -28.36% | ― | 12.74% | -392.59% | |
49 Neutral | AU$74.90M | -8.57 | -164.39% | ― | ― | 15.66% | |
45 Neutral | AU$46.25M | -2.58 | -664.09% | ― | 20.65% | 15.54% |
Eden Innovations Ltd has lodged details of a proposed capital raising with the ASX, outlining plans to issue up to 2.2 million convertible notes and 20 million options exercisable at A$0.07 and expiring on 8 September 2027. The proposed placement, scheduled for issue on 13 January 2026, is expected to strengthen the company’s funding position and provide additional financial flexibility, with potential dilution for existing shareholders but also offering scope to support future growth initiatives and operational needs.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations has secured a $2.2 million strategic convertible note from 7 Enterprises Pty Ltd to eliminate its remaining $2.7 million iBorrow loan, removing a high‑cost debt facility that was costing more than $1 million annually in interest and servicing. By fully repaying the iBorrow facility and replacing it with capitalised‑interest funding secured over a US property, Eden materially strengthens its balance sheet, reduces near‑term refinancing and cash flow risk, and improves the translation of its accelerating revenue growth—particularly in the US, OptiBlend quotations, and EdenCrete sales in Ecuador—into free cash flow, leaving the company better positioned for 2026 with institutional investor backing.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations has disclosed a change in the interests of director Doug Solomon, detailing adjustments to his direct and indirect holdings in the company’s shares and options. The change stems from a partial repayment of an outstanding loan through the issue of 28,571,428 fully paid ordinary shares and 14,285,714 unlisted options at a deemed price of A$0.035 per share, following shareholder approval on 18 December 2025, resulting in a substantial increase in Solomon’s indirect equity and option position and further aligning his interests with those of shareholders.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations has disclosed a significant change in the holdings of director Gregory Howard Solomon, following a shareholder-approved transaction that partially repaid an outstanding loan via the issue of new equity. Solomon, through his direct and indirect interests including Arkenstone Pty Ltd entities, acquired 28,571,428 fully paid ordinary shares and 14,285,714 unlisted options (exercisable at $0.07, expiring 8 September 2027) at a deemed price of $0.035 per share, increasing his indirect shareholding to 101,759,990 shares and unlisted options at $0.07 to 18,285,714. The transaction strengthens Eden Innovations’ balance sheet by reducing debt while further consolidating Solomon’s position as a key shareholder, underlining a strong alignment between the director’s interests and those of other investors.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations has issued 7,142,857 fully paid ordinary shares to Noble Energy Pty Ltd as the second tranche of an agreed share placement, and a further 57,142,856 fully paid ordinary shares to Arkenstone Pty Ltd and March Bells Pty Ltd, entities associated with directors Greg Solomon and Doug Solomon, in repayment of loans. The company confirmed that these placement and loan repayment shares were issued without the need for a prospectus under the Corporations Act disclosure provisions and that it remains compliant with its financial reporting and continuous disclosure obligations, with no additional undisclosed information required at this time, clarifying the regulatory status of the new equity for existing and new shareholders.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations has notified the market that it has issued 3,571,428 unquoted options, each exercisable at A$0.07 and expiring on 8 September 2027. The options, which form part of previously announced transactions and are not intended to be quoted on the ASX, modestly expand the company’s pool of equity-linked securities and may provide additional future capital if exercised, with limited immediate impact on existing shareholders given their unquoted status.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations has notified the market of the issue of 28,571,428 unquoted options, exercisable at $0.07 and expiring on 8 September 2027. The options, which are not intended to be quoted on the ASX, form part of a previously announced transaction and signal a fresh round of equity-linked incentives or funding that may influence the company’s future capital structure and potential shareholder dilution.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations Ltd has applied for quotation of 57,142,856 new fully paid ordinary shares on the Australian Securities Exchange, with an issue date of 19 December 2025. The enlarged quoted capital base is expected to provide the company with additional flexibility in capital management and may have implications for existing shareholders through dilution and enhanced liquidity in the stock.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations Ltd announced that all resolutions presented during its General Meeting on December 18, 2025, were successfully passed via polls without amendment. The resolutions dealt with the issuance of securities for debt conversion and other corporate matters, indicating a step forward in the company’s financial and strategic positioning. This marks a positive development, potentially enhancing Eden Innovations’ operational capabilities and strengthening relations with key stakeholders.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations has secured its largest order to date from Holcim Ecuador for its EdenCrete®Pz7 product, valued at approximately A$514,833. This order signifies a growing demand for Eden’s product, with expectations for annual sales to Holcim Ecuador to reach around US$800,000. The ongoing relationship with Holcim, a major player in the global cement and concrete industry, is crucial for Eden’s strategic goal of achieving positive cash flow by 2026.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations Ltd announced that all resolutions were passed at its Annual General Meeting, including the appointment of Stantons International Audit and Consulting Pty Ltd as the new external auditor. This change in auditor, effective immediately, marks a significant shift in the company’s financial oversight. The successful passing of all resolutions, including the approval of the Employee Securities Incentive Plan and a 10% Placement Facility, indicates strong shareholder support and positions the company for future strategic initiatives.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations Limited has released a presentation at their Annual General Meeting, highlighting the company’s strategic focus on enhancing its competitive position in the nanomaterials and fuel reduction sectors. The announcement underscores potential growth opportunities and challenges, including market acceptance, regulatory compliance, and economic conditions, which could impact Eden’s operational results and stakeholder interests.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
Eden Innovations Ltd has announced an upcoming General Meeting of Shareholders scheduled for December 18, 2025, in Perth, Western Australia. The meeting will address key company matters, and shareholders are encouraged to participate either in person or via proxy. The company has made the meeting materials available online, reflecting a commitment to accessibility and transparency. This meeting is significant for stakeholders as it provides an opportunity to engage with the company’s strategic direction and governance.
Eden Innovations Ltd announced the issuance of over 20 million unquoted securities, which are set to expire in September 2027. This move is part of previously announced transactions, and it highlights the company’s ongoing efforts to manage its equity and financial strategies effectively, potentially impacting its market positioning and stakeholder interests.
Eden Innovations Ltd has issued 117,085,716 fully paid ordinary shares to sophisticated and professional investors at $0.035 per share. This issuance, part of a shortfall securities offer, is intended to strengthen the company’s financial position and support its ongoing projects, reflecting a strategic move to bolster its market presence.
Eden Innovations Ltd announced a proposed issue of securities, including 57,142,856 ordinary fully paid shares and 28,571,428 options expiring in September 2027. This strategic move is aimed at raising capital to support the company’s ongoing projects and growth initiatives, potentially strengthening its market position and offering new opportunities for stakeholders.
Eden Innovations Ltd announced the issuance of 58,542,857 unquoted securities, set to expire in September 2027, as part of a previously announced transaction. This move could potentially enhance the company’s financial flexibility and strategic positioning in its market, impacting stakeholders by possibly increasing the company’s operational capacity and market reach.
Eden Innovations Ltd has announced the application for the quotation of 117,085,716 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions, indicating a strategic effort to enhance the company’s financial flexibility and market presence.
Eden Innovations Ltd has announced an update to its previous statement regarding the proposed issue of securities, with the new issue date set for 18 November 2025. This update is part of the company’s strategic financial maneuvers, potentially impacting its market positioning and offering stakeholders insights into its future growth and operational plans.
Eden Innovations Ltd has successfully secured commitments to raise approximately $4.35 million through a placement of shortfall securities from its recent entitlement offer. This capital will support the marketing and commercialization of its products, EdenCrete® and OptiBlend®, and is part of the company’s financial restructuring efforts, which also included the sale of a property in Georgia to repay debt.
Eden Innovations Ltd has successfully completed the sale of its Georgia property for US$5 million, significantly reducing its debt. The proceeds were used to repay a substantial portion of the iBorrow loan, decreasing the company’s total debt by approximately 70% to AUD $5.2 million. This financial restructuring, alongside growing sales of its core products, positions Eden for a more stable financial future.
Eden Innovations Ltd reported its quarterly activities, highlighting significant developments in its EdenCrete® and OptiBlend® product lines. The company achieved notable sales in the US and secured its first Canadian order for EdenCrete®Pz7, marking a strategic expansion into the Canadian market. Additionally, Eden is exploring new applications for its products, such as electromagnetic pulse protection in data centers. These advancements indicate Eden’s growing influence in the construction materials sector and its commitment to expanding its market presence.
Eden Innovations Ltd announced the upcoming Annual General Meeting (AGM) scheduled for November 28, 2025, at their Perth office. The notice and related documents are available online, and shareholders are encouraged to lodge their proxy forms digitally. This meeting is a significant event for stakeholders, providing insights into the company’s strategic direction and operational updates.
Eden Innovations Ltd has reported a significant increase in orders for its OptiBlend kits, with recent sales to US data centers reaching USD$487,000, which is 80% of their total annual US sales for FY 2025. This surge in demand, including a notable order for a US court, positions the company to exceed its previous annual sales figures by 30% with eight months remaining in FY 2026, highlighting a strong market presence and potential growth in the energy efficiency sector.
Eden Innovations has reported a surge in demand for its OptiBlend dual fuel kits, particularly from US data centers, resulting in new orders and a robust sales pipeline. The OptiBlend kits, which extend the operational time of generators and reduce fuel costs and emissions, have become increasingly attractive to data centers due to their efficiency and cost-effectiveness. With the North American data center market projected to grow significantly, Eden Innovations is well-positioned to capitalize on this trend, as evidenced by recent orders and a substantial pipeline of active quotes.
Eden Innovations Ltd announced the impending sale of its Georgia property for US$5 million, significantly higher than its purchase price in 2018. The sale is expected to close on November 3, 2025, and will allow the company to repay a substantial portion of its iBorrow loan, thereby reducing ongoing financing costs and improving financial stability.